Lipella Pharmaceuticals Inc. (LIPO) Ownership
LIPO ownership summary
as of October 21, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 6.31% of shares outstanding
- Shares outstanding
- 4.6M
- Float
- 4.3M shares available to trade
- Short interest
- 1.57% 100K shares short
- Days to cover
- 1.82 short interest down 17.6% vs prior month
- Insiders 6.31%
- Other investors 93.69%
LIPO top institutional holders
4 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Tower Research Capital LLC | 0.00% | — | — | −2,708 (−100.0%) | June 30, 2025 |
| 2 | Mccormack Advisors International | 0.00% | — | — | −125 (−100.0%) | June 30, 2025 |
| 3 | Virtu Financial LLC | 0.00% | — | — | −13,310 (−100.0%) | March 31, 2025 |
| 4 | Bank of America Corp | 0.00% | — | — | −7 (−100.0%) | June 30, 2025 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 4, 0 holders added 0 shares and 4 cut 16K.
LIPO top mutual fund and ETF holders
3 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Extended Market Index | 0.13% | 5,778 | $3 | — | May 31, 2025 |
| 2 | Vanguard Institutional Extnd Mkt Idx Tr | 0.10% | 4,314 | $2 | — | May 31, 2025 |
| 3 | Fidelity Series Total Market Index | 0.03% | 1,341 | $1 | — | May 31, 2025 |
Funds report holdings monthly or quarterly; dates differ by fund.
LIPO insider transactions
latest 2| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2024-05-14 | Jonathan H Kaufman | Buy | $6.08 | 1,250 | $7,600 |
| 2024-03-18 | Jonathan H Kaufman | Buy | $6.32 | 3,750 | $23,700 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LIPO shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LIPO
Institutional investors own 0.0% of Lipella Pharmaceuticals's shares and insiders 6.31%. The largest holder is Tower Research Capital LLC with 0.00% of the shares (0), as of June 30, 2025. Among the top 4 institutions, 0 added shares and 4 reduced their stake in the latest filings. Short interest is 1.57% of the float, or 1.82 days of average trading volume. The share count rose 354.9% since 2020.
Related: LIPO analyst forecast, LIPO key metrics. See the LIPO stock overview for the latest quote and news.
LIPO ownership FAQ
Who owns the most Lipella Pharmaceuticals stock?
The largest shareholders of Lipella Pharmaceuticals are Tower Research Capital LLC (0.00%), Mccormack Advisors International (0.00%), Virtu Financial LLC (0.00%), Bank of America Corp (0.00%).
What percentage of Lipella Pharmaceuticals is owned by institutions?
Institutions hold 0.0% of Lipella Pharmaceuticals's shares outstanding; insiders hold 6.31%.
Which funds own Lipella Pharmaceuticals?
The largest fund holders of Lipella Pharmaceuticals are Fidelity Extended Market Index (0.13%), Vanguard Institutional Extnd Mkt Idx Tr (0.10%), Fidelity Series Total Market Index (0.03%).
What is Lipella Pharmaceuticals's short interest?
100K shares of Lipella Pharmaceuticals were sold short, 1.57% of the float; at the average daily volume it would take 1.82 days to cover.
Are insiders buying or selling Lipella Pharmaceuticals?
Of the latest 2 reported insider transactions in Lipella Pharmaceuticals (since March 18, 2024), 2 were purchases and 0 were sales.
How many shares of Lipella Pharmaceuticals are outstanding?
Lipella Pharmaceuticals has 4.6M shares outstanding, of which 4.3M are in the public float.